Skip to main content
Fig. 1 | Clinical Proteomics

Fig. 1

From: Integrating the serum proteomic and fecal metaproteomic to analyze the impacts of overweight/obesity on IBD: a pilot investigation

Fig. 1

Workflow of the human experiments. Control subject, HC; Crohn's disease, CD; Ulcerative colitis, UC. For ease of representation, we here denote “with-overweight/obesity” by “F” and “without-overweight/obesity” by “NF”. Six subgroups were exhibited as UC_F, UC_NF, CD_F, CD_NF, HC_F, and HC_NF

Back to article page

Clinical Proteomics

ISSN: 1559-0275